BCRX
Price
$8.22
Change
+$0.26 (+3.27%)
Updated
Apr 24 closing price
Capitalization
1.72B
6 days until earnings call
SGMO
Price
$0.81
Change
+$0.06 (+8.00%)
Updated
Apr 24 closing price
Capitalization
183.12M
5 days until earnings call
Ad is loading...

BCRX vs SGMO

Header iconBCRX vs SGMO Comparison
Open Charts BCRX vs SGMOBanner chart's image
BioCryst Pharmaceuticals
Price$8.22
Change+$0.26 (+3.27%)
Volume$3.31M
Capitalization1.72B
Sangamo Therapeutics
Price$0.81
Change+$0.06 (+8.00%)
Volume$6.32M
Capitalization183.12M
BCRX vs SGMO Comparison Chart
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCRX vs. SGMO commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a Buy and SGMO is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BCRX: $8.22 vs. SGMO: $0.81)
Brand notoriety: BCRX: Notable vs. SGMO: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 89% vs. SGMO: 83%
Market capitalization -- BCRX: $1.72B vs. SGMO: $183.12M
BCRX [@Biotechnology] is valued at $1.72B. SGMO’s [@Biotechnology] market capitalization is $183.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileSGMO’s FA Score has 0 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • SGMO’s FA Score: 0 green, 5 red.
According to our system of comparison, BCRX is a better buy in the long-term than SGMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 6 TA indicator(s) are bullish while SGMO’s TA Score has 4 bullish TA indicator(s).

  • BCRX’s TA Score: 6 bullish, 3 bearish.
  • SGMO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BCRX is a better buy in the short-term than SGMO.

Price Growth

BCRX (@Biotechnology) experienced а +11.08% price change this week, while SGMO (@Biotechnology) price change was +15.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

BCRX is expected to report earnings on Jul 31, 2025.

SGMO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($1.72B) has a higher market cap than SGMO($183M). BCRX YTD gains are higher at: 9.309 vs. SGMO (-20.108). BCRX has higher annual earnings (EBITDA): 12.8M vs. SGMO (-123.99M). BCRX has more cash in the bank: 321M vs. SGMO (39.2M). SGMO has less debt than BCRX: SGMO (27.7M) vs BCRX (809M). BCRX has higher revenues than SGMO: BCRX (451M) vs SGMO (52.3M).
BCRXSGMOBCRX / SGMO
Capitalization1.72B183M939%
EBITDA12.8M-123.99M-10%
Gain YTD9.309-20.108-46%
P/E RatioN/AN/A-
Revenue451M52.3M862%
Total Cash321M39.2M819%
Total Debt809M27.7M2,921%
FUNDAMENTALS RATINGS
BCRX vs SGMO: Fundamental Ratings
BCRX
SGMO
OUTLOOK RATING
1..100
2428
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
64
Fair valued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
4264
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCRX's Valuation (31) in the Biotechnology industry is somewhat better than the same rating for SGMO (64). This means that BCRX’s stock grew somewhat faster than SGMO’s over the last 12 months.

BCRX's Profit vs Risk Rating (65) in the Biotechnology industry is somewhat better than the same rating for SGMO (100). This means that BCRX’s stock grew somewhat faster than SGMO’s over the last 12 months.

SGMO's SMR Rating (96) in the Biotechnology industry is in the same range as BCRX (100). This means that SGMO’s stock grew similarly to BCRX’s over the last 12 months.

BCRX's Price Growth Rating (42) in the Biotechnology industry is in the same range as SGMO (64). This means that BCRX’s stock grew similarly to SGMO’s over the last 12 months.

BCRX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SGMO (100). This means that BCRX’s stock grew similarly to SGMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCRXSGMO
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 18 days ago
80%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRCIX52.65N/A
N/A
Carillon ClariVest Capital Apprec I
BMCAX20.57N/A
N/A
BlackRock Advantage Large Cap Gr Inv A
UIVPX11.24N/A
N/A
MFS Intrinsic Value R3
FDSCX32.55N/A
N/A
Fidelity Stock Selector Small Cap
JSCCX9.47N/A
N/A
JHancock Small Cap Value R6

BCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
+3.27%
VCYT - BCRX
46%
Loosely correlated
+2.15%
OCGN - BCRX
44%
Loosely correlated
+2.78%
ETNB - BCRX
38%
Loosely correlated
+4.23%
DNLI - BCRX
38%
Loosely correlated
+4.17%
ARWR - BCRX
38%
Loosely correlated
+2.54%
More

SGMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with AXON. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
+8.06%
AXON - SGMO
51%
Loosely correlated
+2.39%
ARRY - SGMO
48%
Loosely correlated
+5.31%
BCRX - SGMO
46%
Loosely correlated
+3.27%
RPRX - SGMO
45%
Loosely correlated
+1.07%
AGEN - SGMO
43%
Loosely correlated
-1.05%
More